Mefexamide as an antiparkinson drug. (A double-blind study).
D000577:Amides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005260:Female; D006016:Glycolates / Q000627:therapeutic use*; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D011346:Prochlorperazine / Q000627:therapeutic use; D011352:Procyclidine / Q000627:therapeutic use; D013997:Time Factors
D000577:Amides; D006016:Glycolates; D010276:Parasympatholytics; D011352:Procyclidine; D011346:Prochlorperazine